Fed. Circ. Revives Galderma's Patents On Rosacea Drug
The Federal Circuit on Wednesday vacated a district court's finding that two patents held by Galderma Laboratories Inc. for rosacea drug Oracea were invalid, ruling that the district judge did not...To view the full article, register now.
Already a subscriber? Click here to view full article